Alexander E. Csordas

ALEX CSORDAS focuses his practice on corporate and securities law matters. He represents issuers, underwriters, agents, and selling securityholders in a broad range of SEC-registered and exempt transactions such as initial public offerings (IPOs), follow-on common and preferred equity offerings, and debt offerings. He represents clients across a diverse set of sectors, including life sciences, technology, healthcare, industrials, consumer staples, financial services, and real estate. Alex has experience with cross-border transactions and offerings of bonds denominated in foreign currencies. He also advises clients on corporate governance matters and public company reporting obligations.

While attending law school, Alex served as an executive articles editor on the Brooklyn Journal of International Law. He received his undergraduate degree from Washington and Lee University.

Representative transactions and experience include:

• Lumexa Imaging Holdings, Inc. in its US$462.5 million IPO.
• Goldman Sachs & Co. LLC, Morgan Stanley, and the other underwriters in the $1.5 billion offering of senior notes by Southwest Airlines Co.
• J.P. Morgan, BofA Securities, Morgan Stanley, and the other underwriters in the public offering of US$260.0 million of shares of common stock of Redwire Corporation in connection with its acquisition of Edge Autonomy.
• Morgan Stanley and the other underwriters in the public offering on a forward sale basis of US$402.5 million of shares of common stock of Atlantic Union Bankshares Corporation to finance its merger with Sandy Spring Bancorp Inc.
• J.P. Morgan, BofA Securities, Wells Fargo Securities, and the other underwriters in the public offering of US$257.6 million of shares of common stock of InvenTrust Properties Corp.
• Goldman Sachs & Co. LLC, Morgan Stanley, and RBC Capital Markets in the secondary public offerings of an aggregate of US$620.8 million of shares of common stock of V2X, Inc.
• Stonepeak Infrastructure Partners in its sale of US$607.7 million of common units representing limited partner interests of Energy Transfer LP in an underwritten public offering.
• Baird, Goldman Sachs & Co. LLC, and Morgan Stanley in secondary public offerings of an aggregate of US$429.9 million of shares of common stock of REV Group, Inc.
• CMS Energy Corporation in the issuance of US$800 million aggregate principal amount of 3.375% Convertible Senior Notes due 2028, its inaugural convertible notes offering, and concurrent US$150 million cash tender offer.
• Citigroup, MUFG, and the other underwriters in the ¥110.1 billion offering of senior notes by Thermo Fisher Scientific, its inaugural yen-denominated debt offering.
• The underwriters in connection with John Deere’s US$600 million sustainability-linked bond, its inaugural ESG bond offering.
• Jackson Financial in the issuance of US$1.6 billion aggregate principal amount of senior notes, its inaugural debt offering following its spin-off from Prudential plc.
• The underwriters in an acquisition financing for Thermo Fisher Scientific of over US$18 billion of fixed and floating rate notes denominated in euros and U.S. dollars.
• BofA Securities and the other underwriters in the US$198.7 million IPO of Tyra Biosciences.
• Morgan Stanley and the other underwriters in the US$129.4 million IPO of Immuneering Corporation.
• Morgan Stanley, J.P. Morgan, and the other underwriters in the US$322.7 million IPO of Bridge Investment Group Holdings Inc.
• The underwriters in connection with Norfolk Southern’s US$500 million green bond to fund sustainable business initiatives, the first green bond offering by a Class I railroad in North America.
• Goldman Sachs & Co. LLC, J.P. Morgan, and the other underwriters in the US$400 million offering of senior notes by Safehold Inc., its inaugural debt offering.
• Morgan Stanley and the other underwriters in the US$190.2 million IPO of Pharvaris N.V.
• The underwriters in connection with Morgan Stanley’s US$1 billion social bond to support affordable housing projects, its inaugural social bond offering.
• Aprea Therapeutics, Inc. in its US$98 million IPO.
• The underwriters in connection with Morgan Stanley’s offering of US$750 million of floating rate notes based on the Secured Overnight Financing Rate (SOFR), the first public offering of SOFR notes by a large U.S. financial institution and the winner of “Debt and Equity-linked Deal of the Year” at the 2020 IFLR Americas Awards.
• Mizuho, SMBC Nikko, and the other initial purchasers in the ¥4.5 billion offering of senior notes by Cantor Fitzgerald, its inaugural yen-denominated debt offering.
• Essential Properties Realty Trust in its US$455 million IPO, subsequent US$245.5 million follow-on equity offering, and ongoing disclosure obligations.
• Goldman Sachs & Co. LLC and the other initial purchasers in the US$550 million offering of senior notes by Newmark Group, Inc., its inaugural debt offering.
• BofA Securities and the other underwriters in the US$235.8 million IPO of Safehold Inc.
• UBS Investment Bank and the other underwriters in the US$480.0 million IPO of Industrial Logistics Properties Trust.
• Nektar Therapeutics in connection with its public offering of US$200 million of shares of common stock.
• eBay Inc. in the US$1.4 billion sale of its 18.4% holding in MercadoLibre, Inc., the largest e-commerce platform in Latin America.
• Numerous financings for BBVA, BGC Group, Camden Property Trust, Cantor Fitzgerald, Consumers Energy, Harley-Davidson, Hexcel Corporation, Jackson Financial, John Deere, Morgan Stanley, Newmark, Norfolk Southern Corporation, O’Reilly Automotive, PACCAR Inc., Realty Income Corporation, Safehold, Smith+Nephew, Thermo Fisher Scientific, and various other issuers.